Pediatric Genetic Testing Market Forecast: Projected 14% CAGR by 2028, Evaluating Size, Share, Demand, Future Growth, and Competitive Analysis
The report indicates that the Pediatric Genetic Testing Market is anticipated to experience a CAGR of approximately 14% during the period of 2023-2028. Our analysis encompasses a thorough examination of various environmental factors, economic and social issues, technological advancements, and other relevant aspects that are crucial for stakeholders during decision-making processes. In order to provide a reliable, accurate, and comprehensive understanding of the industry, our analysts have conducted extensive research utilizing tools such as SWOT (Strengths, Weaknesses, Opportunities, and Threats) analysis and Porter's Five Forces Analysis.
Get Your Complimentary Sample Report Now! https://www.marknteladvisors.com/query/request-sample/global-pediatric-genetic-testing-market.html
Key Driver: Ever-Increasing Demand for Molecular Testing to Diagnose Cancer
Molecular tests verify the diagnosis, project a prognosis and help formulate a treatment plan for children who have cancer or showing the risk of developing cancer. Besides, they play a crucial role in providing genetic counseling and prenatal diagnosis to the family as well. Owing to the potential benefits of molecular testing in diagnosing cancer and enabling people to make informed decisions about managing their children's health care have encouraged the incorporation of genetic-based tests over the course of time, accelerating the market forward.
• In December 2022, one of the leading medical genetics businesses, Invitae Corporation, announced the introduction of the Rare Patient Network, which expands Invitae's Citizen platform to all children with pediatric epilepsy and developmental delay. Invitae, a pioneer in rare pediatric neurodevelopmental disorders, wants to benefit much more sufferers of rare diseases by interacting with a larger community.
Segmenting Success: Unveiling Opportunities in the Pediatric Genetic Testing Market 2023-2028
The Pediatric Genetic Testing Market, characterized by its fragmented nature and numerous subdivisions, is thoroughly examined in the report. We provide detailed insights on each segment and geographical location, empowering stakeholders and industry leaders to comprehend the market dynamics and devise new strategies and investments. Furthermore, by gaining a deeper understanding of the ebb and flow within each segment, investors can make well-informed decisions and expand their production and revenue streams in the coming years. The report focuses on key market dynamics, including recent developments, trends, demand and supply chain analysis, purchase patterns, and product/service pricing, among others, within the following segments:
Based on Product Type
- Laboratory Developed Tests (LDT)
Based on Sample Type
- Bone Marrow
Based on Technology
- Next Generation Sequencing
- Fluorescent In Situ Hybridization (FISH)
- Polymerase Chain Reaction
- Microarray Techniques
Based on Disorder
- Developmental Disorders
- Cardiovascular Disorders
- Neurological Disorders
Based on Application
- Clinical Diagnostics
- Drug Discovery
- Monitoring and Screening
- Academic and Research
Based on Origin
- Inherited Disorders
- Somatic Disorders
Geographically, the Pediatric Genetic Testing Market expands across the following:
- North America
- South America
- Middle East & Africa
Immerse Yourself in the Complete Report: Explore Extensive Research, Market Segmentation, and Competitive Landscape Analysis - https://www.marknteladvisors.com/research-library/global-pediatric-genetic-testing-market.html
Unveiling the Competitive Landscape: Insights into Key Players in the Pediatric Genetic Testing Market 2023-2028
The report provides a comprehensive competitive analysis, highlighting a key aspect of the industry-the existing players. Each player is extensively profiled, covering vital aspects such as business overview, demand and supply chain, key strategies, latest news, product launches, pricing catalog, recent developments, revenue generation, stakes and investments, and trends. These insights aim to assist stakeholders in diversifying and strategizing their investments and participation in the Pediatric Genetic Testing Market, ultimately seeking substantial revenue generation over the forecasted years.
- Abbott Laboratories
- BGI Genomics
- Invitae Corporation
- Trivitron Healthcare
- Thermo Fisher Scientific Inc.
- Fulgent Genetics, Inc.
- Quest Diagnostics
- Unilabs Group Services
- Agilent Technologies, Inc.
- Genomic Diagnostics
- PerkinElmer, Inc.
- CENTOGENE N.V
- OPKO Health, Inc.
- Baebies, Inc.
- Eurofins Scientific
Company Name: MarkNtel Advisors
Phone: +1 628 895 8081 +91 120 4268433,
Address: 5214F Diamond Heights Blvd #3092,
San Francisco, CA 94131
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Using such information, our clients can identify attractive investment opportunities & strategize their moves to yield higher ROI (Return of Interest) through an early mover advantage with top-management approaches.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pediatric Genetic Testing Market Forecast: Projected 14% CAGR by 2028, Evaluating Size, Share, Demand, Future Growth, and Competitive Analysis here
News-ID: 3084100 • Views: 485
More Releases from MarkNtel Advisors LLP
Hypersonic Technology Market Growth, Share, Trends Analysis, Demand, Business Ch …
Markntel Advisors' recent report projects that The Global Hypersonic Technology Market is anticipated to grow at a CAGR of around 8% during the forecast period 2021-28. This study, produced by one of the leading market research organisations, gives critical insights into key players market positioning, addressing critical issues such as product pricing, costs, earnings, production, capacity utilization, supply and demand dynamics, and industry growth rates. Specialized portions of the research
Data Governance Market Share, Growth, Size, Revenue, Trends Analysis, Key Player …
Markntel Advisors' recent report projects that The Global Data Governance Market is anticipated to grow at a CAGR of around 22% during 2020-25. This study, produced by one of the leading market research organisations, gives critical insights into key players market positioning, addressing critical issues such as product pricing, costs, earnings, production, capacity utilization, supply and demand dynamics, and industry growth rates. Specialized portions of the research are devoted to
Microgrid Market Growth, Rising Trends, Share, Scope, Revenue, Key Manufacturers …
Markntel Advisors' recent report projects that The Global Microgrid Market is anticipated to grow at a CAGR of less than 12% during 2020-25. This study, produced by one of the leading market research organisations, gives critical insights into key players market positioning, addressing critical issues such as product pricing, costs, earnings, production, capacity utilization, supply and demand dynamics, and industry growth rates. Specialized portions of the research are devoted to
Collagen Peptides Market Growth, Share, Trends Analysis, Impact on Covid-19, Cha …
Markntel Advisors' recent report projects that The Global Collagen Peptides Market is anticipated to grow at a CAGR of around 9.5% during 2020-25F. This study, produced by one of the leading market research organisations, gives critical insights into key players market positioning, addressing critical issues such as product pricing, costs, earnings, production, capacity utilization, supply and demand dynamics, and industry growth rates. Specialized portions of the research are devoted to
More Releases for Genetic
Genetic Testing Market to Register Growth due to Increasing Prevalence of Geneti …
The prevalence of diseases, including chronic and genetic diseases, is rising at a swift pace. According to the World Health Organization, a genetic disorder named sickle cell anemia is primarily common among people who had ancestors in India, South America, Central America, Sub-Saharan Africa, Mediterranean countries (including Greece, Turkey, and Italy), Cuba, and Saudi Arabia. In addition to this, the high prevalence of chronic diseases, such as cancer, is also
Genetic Testing Market Demand 2018; by Method Molecular Genetic Test/ DNA Test, …
Universal Genetic Testing Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Genetic Testing market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023. Genetic Testing Market - Global Insights The Global Genetic Testing Market is growing with the rapid
Global Preimplantation Genetic Testing Market: Growing Public-Private Investment …
The report "Preimplantation Genetic Testing Market by Products & Services (Reagents and Consumables, Software and Services and Instruments), Technology (Single-Nucleotide Polymorphism, Next-Generation Sequencing, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization and Polymerase Chain Reaction), Procedure Type (Preimplantation Genetic Screening, and Preimplantation Genetic Diagnosis), Application (Single Gene Disorders, HLA Typing, Structural Chromosomal Abnormalities, X-Linked Disorders, Aneuploidy and Gender Identification), End User (Hospitals, Diagnostic Labs, and Service Providers, Research Laboratories & Academic
Reproductive Genetic Innovations to Discuss Novelties in Preimplantation Genetic …
Reproductive Genetic Innovations (RGI) will be attending and presenting at the 54th Mexican Congress of Reproductive Medicine hosted by the Associacion Mexicana de Medicina de la Reproduccion, A.C. (AMMR). This is the first year RGI has attended and presented at this conference. Booth G-H (July 17th to the 20th) President and Lab Director, Dr. Svetlana Rechitsky, will be giving a lecture on Wednesday afternoon (July 19th) titled, "Novelties in
Breast Cancer Predictive Genetic Testing Market Breast Cancer Predictive Genetic …
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents Cancer Susceptibility Testing 1.1 Prologue to Cancer Susceptibility 1.2 Aspects of Cancer Susceptibility Testing Breast Cancer Susceptibility 2.1 Conceptual of Breast Cancer Susceptibility 2.2 Trail of the Inherited Susceptible Genes Hereditary Breast Cancer Genes 3.1 High Penetrant Genes 3.1.1 Breast Cancer Gene1 (BRCA1) 3.1.2 Breast Cancer Gene 2 (BRCA2)
Rising Prevalence of Genetic Disorders Propels Prenatal and New-born Genetic Tes …
Global Prenatal and New-born Genetic Testing Market: Snapshot Prenatal and new-born genetic tests refer to the systematic diagnostic tests and screenings undertaken to determine the risk of certain genetic disorders in newborn children and fetuses in stages as early as eight to ten weeks of gestation. The use of a variety of screening and diagnostic tools for detecting chromosomal abnormalities and the risk of diseases such as Patau syndrome, Down